• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Biostem Technologies Inc (OP: BSEM )

    11.31 +0.31 (+2.82%)
    Streaming Delayed Price Updated: 10:40 AM EDT, Aug 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 15,083
    Open 11.54
    Bid (Size) N/A (0)
    Ask (Size) N/A (0)
    Prev. Close 11.00
    Today's Range 11.31 - 11.77
    52wk Range 1.470 - 15.50
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    BioStem Technologies Innovative Wound-Care Treatments Steepen Its Growth Trajectory ($BSEM)
    Via AB Newswire
    Exposures Product Safety
    BioStem Technologies Inc. In A Race To The Top With Innovative Wound-Care Treatments ($BSEM)
    Via AB Newswire
    Topics Intellectual Property
    Exposures Intellectual Property Product Safety

    Performance

    YTD
    +86.17%
    +86.17%
    1 Month
    +38.43%
    +38.43%
    3 Month
    +42.26%
    +42.26%
    6 Month
    +22.27%
    +22.27%
    1 Year
    +561.40%
    +561.40%

    More News

    Read More
    BioStem Technologies Announces Opening of First Clinical Site for Diabetic Foot Ulcer Study
    Via ACCESSWIRE
    BioStem Technologies to Highlight Core Advanced Wound Care Portfolio at SAWC Fall 2023 Conference
    Via ACCESSWIRE
    BioStem Technologies: CMS Decision a “Win For Patients”
    Via ACCESSWIRE
    BioStem Receives IRB Approval for Clinical Study to Evaluate Vendaje(R) in Diabetic Foot Ulcers
    Via ACCESSWIRE
    BioStem Technologies Initiates Nationwide Launch of AmnioWrap2(TM) with Venture Medical
    Via ACCESSWIRE
    BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
    Via ACCESSWIRE
    NovaBay Pharmaceuticals Announces Agreement with BioStem Technologies to Commercialize Amniotic Tissue Allograft as Avenova® Allograft
    From NovaBay Pharmaceuticals, Inc.
    Via Business Wire
    How BioStem Plans To Grow Its Perinatal Allografts In 2023 – And Beyond
    Via Benzinga
    2022 Year in Review: BioStem Technologies Looks Back At A Year of Growth And Expansion
    Via Benzinga
    BioStem Technologies Announces Partnership with Kill Cliff FC
    From BioStem Technologies, Inc.
    Via GlobeNewswire
    BioStem Technologies Reports Third Quarter 2022 Operating and Financial Results
    From BioStem Technologies, Inc.
    Via GlobeNewswire
    BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
    From BioStem Technologies, Inc.
    Via GlobeNewswire
    BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
    From BioStem Technologies, Inc.
    Via GlobeNewswire
    BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
    From BioStem Technologies, Inc.
    Via GlobeNewswire
    BioStem Technologies (OTCMKTS: BSEM) Coverage Initiated at Zacks Investment Research
    Via Benzinga
    EXCLUSIVE: BioStem Technologies Reports Q1 Net Revenue Up 211% YoY
    Via Benzinga
    Cannabis Movers & Shakers: Halo Collective, Suite 420 Access, OWP, BioStem, Chicago Atlantic Advisors, Silo Wellness
    Via Benzinga
    Topics Cannabis
    Exposures Cannabis
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.